Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals. [PDF]
Menozzi E +34 more
europepmc +1 more source
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry. [PDF]
Alcalay RN +7 more
europepmc +1 more source
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. [PDF]
Akçimen F +112 more
europepmc +1 more source
Parkinson's disease and Gaucher disease : focus on the GBA1 link [Elektronisk resurs]
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder in the world, characterized by both motor as well as many non-motor features.
Brodin, L,
core
The interplay between GBA1 status and age of onset on cognitive, motor and non-motor outcomes in Parkinson's disease: multicenter cross-sectional study. [PDF]
Ledda C +19 more
europepmc +1 more source
Underlying Mechanisms of GBA1 in Parkinson's Disease and Dementia with Lewy Bodies: Narrative Review. [PDF]
Bougea A.
europepmc +1 more source
Refining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies. [PDF]
Fattahi N +5 more
europepmc +1 more source
Unveiling an Uncommon Glucosylceramidase (GBA) Mutation: Gaucher Disease Due to p.Ser276Phe Substitution. [PDF]
Kumar N +4 more
europepmc +1 more source
Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease. [PDF]
Toffoli M +18 more
europepmc +1 more source
Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. [PDF]
Fang Z +5 more
europepmc +1 more source

